Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.

Eric J ChowRichard AplencLynda M VroomanDavid R DoodyYuan-Shung V HuangSanjeev AggarwalSaro H ArmenianK Scott BakerSmita BhatiaLouis S ConstineDavid R FreyerLisa M KoppWendy M LeisenringBarbara L AsselinCindy L SchwartzSteven E Lipshultz

Published in: Cancer (2021)

Dexrazoxane did not appear to adversely affect long-term mortality, event-free survival, or second cancer risk.

Keyphrases